EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer

Jing Zhang, Chengyang Wang, Xi Chen, Mamoru Takada, Cheng Fan, Xingnan Zheng, Haitao Wen, Yong Liu, Chenguang Wang, Richard G. Pestell, Katherine Aird, William G. Kaelin, Xiaole Shirley Liu, Qing Zhang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The EglN2/PHD1 prolyl hydroxylase is an important oxygen sensor contributing to breast tumorigenesis. Emerging studies suggest that there is functional cross talk between oxygen sensing and mitochondrial function, both of which play an essential role for sustained tumor growth. However, the potential link between EglN2 and mitochondrial function remains largely undefined. Here, we show that EglN2 depletion decreases mitochondrial respiration in breast cancer under normoxia and hypoxia, which correlates with decreased mitochondrial DNA in a HIF1/2α-independent manner. Integrative analyses of gene expression profile and genomewide binding of EglN2 under hypoxic conditions reveal nuclear respiratory factor 1 (NRF1) motif enrichment in EglN2-activated genes, suggesting NRF1 as an EglN2 binding partner. Mechanistically, by forming an activator complex with PGC1α and NRF1 on chromatin, EglN2 promotes the transcription of ferridoxin reductase (FDXR) and maintains mitochondrial function. In addition, FDXR, as one of effectors for EglN2, contributes to breast tumorigenesis in vitro and in vivo. Our findings suggest that EglN2 regulates mitochondrial function in ERα-positive breast cancer.

Original languageEnglish (US)
Pages (from-to)2953-2970
Number of pages18
JournalEMBO Journal
Volume34
Issue number23
DOIs
StatePublished - Dec 2 2015

Fingerprint

Nuclear Respiratory Factor 1
Breast Neoplasms
Oxidoreductases
Carcinogenesis
Breast
Oxygen
Prolyl Hydroxylases
Mitochondrial DNA
Transcriptome
Oxygen sensors
Chromatin
Respiration
Transcription
Gene expression
Tumors
Genes
Growth
Neoplasms

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Zhang, J., Wang, C., Chen, X., Takada, M., Fan, C., Zheng, X., ... Zhang, Q. (2015). EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer. EMBO Journal, 34(23), 2953-2970. https://doi.org/10.15252/embj.201591437
Zhang, Jing ; Wang, Chengyang ; Chen, Xi ; Takada, Mamoru ; Fan, Cheng ; Zheng, Xingnan ; Wen, Haitao ; Liu, Yong ; Wang, Chenguang ; Pestell, Richard G. ; Aird, Katherine ; Kaelin, William G. ; Liu, Xiaole Shirley ; Zhang, Qing. / EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer. In: EMBO Journal. 2015 ; Vol. 34, No. 23. pp. 2953-2970.
@article{847fd12bfbd54789b97d4d569e19c913,
title = "EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer",
abstract = "The EglN2/PHD1 prolyl hydroxylase is an important oxygen sensor contributing to breast tumorigenesis. Emerging studies suggest that there is functional cross talk between oxygen sensing and mitochondrial function, both of which play an essential role for sustained tumor growth. However, the potential link between EglN2 and mitochondrial function remains largely undefined. Here, we show that EglN2 depletion decreases mitochondrial respiration in breast cancer under normoxia and hypoxia, which correlates with decreased mitochondrial DNA in a HIF1/2α-independent manner. Integrative analyses of gene expression profile and genomewide binding of EglN2 under hypoxic conditions reveal nuclear respiratory factor 1 (NRF1) motif enrichment in EglN2-activated genes, suggesting NRF1 as an EglN2 binding partner. Mechanistically, by forming an activator complex with PGC1α and NRF1 on chromatin, EglN2 promotes the transcription of ferridoxin reductase (FDXR) and maintains mitochondrial function. In addition, FDXR, as one of effectors for EglN2, contributes to breast tumorigenesis in vitro and in vivo. Our findings suggest that EglN2 regulates mitochondrial function in ERα-positive breast cancer.",
author = "Jing Zhang and Chengyang Wang and Xi Chen and Mamoru Takada and Cheng Fan and Xingnan Zheng and Haitao Wen and Yong Liu and Chenguang Wang and Pestell, {Richard G.} and Katherine Aird and Kaelin, {William G.} and Liu, {Xiaole Shirley} and Qing Zhang",
year = "2015",
month = "12",
day = "2",
doi = "10.15252/embj.201591437",
language = "English (US)",
volume = "34",
pages = "2953--2970",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "Nature Publishing Group",
number = "23",

}

Zhang, J, Wang, C, Chen, X, Takada, M, Fan, C, Zheng, X, Wen, H, Liu, Y, Wang, C, Pestell, RG, Aird, K, Kaelin, WG, Liu, XS & Zhang, Q 2015, 'EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer', EMBO Journal, vol. 34, no. 23, pp. 2953-2970. https://doi.org/10.15252/embj.201591437

EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer. / Zhang, Jing; Wang, Chengyang; Chen, Xi; Takada, Mamoru; Fan, Cheng; Zheng, Xingnan; Wen, Haitao; Liu, Yong; Wang, Chenguang; Pestell, Richard G.; Aird, Katherine; Kaelin, William G.; Liu, Xiaole Shirley; Zhang, Qing.

In: EMBO Journal, Vol. 34, No. 23, 02.12.2015, p. 2953-2970.

Research output: Contribution to journalArticle

TY - JOUR

T1 - EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer

AU - Zhang, Jing

AU - Wang, Chengyang

AU - Chen, Xi

AU - Takada, Mamoru

AU - Fan, Cheng

AU - Zheng, Xingnan

AU - Wen, Haitao

AU - Liu, Yong

AU - Wang, Chenguang

AU - Pestell, Richard G.

AU - Aird, Katherine

AU - Kaelin, William G.

AU - Liu, Xiaole Shirley

AU - Zhang, Qing

PY - 2015/12/2

Y1 - 2015/12/2

N2 - The EglN2/PHD1 prolyl hydroxylase is an important oxygen sensor contributing to breast tumorigenesis. Emerging studies suggest that there is functional cross talk between oxygen sensing and mitochondrial function, both of which play an essential role for sustained tumor growth. However, the potential link between EglN2 and mitochondrial function remains largely undefined. Here, we show that EglN2 depletion decreases mitochondrial respiration in breast cancer under normoxia and hypoxia, which correlates with decreased mitochondrial DNA in a HIF1/2α-independent manner. Integrative analyses of gene expression profile and genomewide binding of EglN2 under hypoxic conditions reveal nuclear respiratory factor 1 (NRF1) motif enrichment in EglN2-activated genes, suggesting NRF1 as an EglN2 binding partner. Mechanistically, by forming an activator complex with PGC1α and NRF1 on chromatin, EglN2 promotes the transcription of ferridoxin reductase (FDXR) and maintains mitochondrial function. In addition, FDXR, as one of effectors for EglN2, contributes to breast tumorigenesis in vitro and in vivo. Our findings suggest that EglN2 regulates mitochondrial function in ERα-positive breast cancer.

AB - The EglN2/PHD1 prolyl hydroxylase is an important oxygen sensor contributing to breast tumorigenesis. Emerging studies suggest that there is functional cross talk between oxygen sensing and mitochondrial function, both of which play an essential role for sustained tumor growth. However, the potential link between EglN2 and mitochondrial function remains largely undefined. Here, we show that EglN2 depletion decreases mitochondrial respiration in breast cancer under normoxia and hypoxia, which correlates with decreased mitochondrial DNA in a HIF1/2α-independent manner. Integrative analyses of gene expression profile and genomewide binding of EglN2 under hypoxic conditions reveal nuclear respiratory factor 1 (NRF1) motif enrichment in EglN2-activated genes, suggesting NRF1 as an EglN2 binding partner. Mechanistically, by forming an activator complex with PGC1α and NRF1 on chromatin, EglN2 promotes the transcription of ferridoxin reductase (FDXR) and maintains mitochondrial function. In addition, FDXR, as one of effectors for EglN2, contributes to breast tumorigenesis in vitro and in vivo. Our findings suggest that EglN2 regulates mitochondrial function in ERα-positive breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=84956764383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956764383&partnerID=8YFLogxK

U2 - 10.15252/embj.201591437

DO - 10.15252/embj.201591437

M3 - Article

VL - 34

SP - 2953

EP - 2970

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 23

ER -